Lion Point Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-115,898	Closed	-$122K	–	29
2023 Q4	$122K	Hold	115,898	–	–	0.06%	25
2023 Q3	$794K	Buy	115,898 +6,000	+5%	+$41.1K	0.35%	16
2023 Q2	$1.14M	Hold	109,898	–	–	0.52%	12
2023 Q1	$889K	Buy	+109,898	New	+$889K	0.37%	19